Real-world experience of nivolumab in the treatment of poor performance status patients with advanced non-small cell lung cancer. - Abbas MN; Klevansky M; Koczwara B; Roy AC; Sukumaran S; Vatandoust S; Karapetis CS (Cancer reports (Hoboken, N.J.), 2022)